MolNFT v1 · #97050 · protein
4,4-dioxo-5,6-dihydro-[1,4,3]OXATHIAZINES, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes
4K26: “4,4-dioxo-5,6-dihydro-[1,4,3]OXATHIAZINES, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes”. X-ray diffraction. MolNFT v1 #97050 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4K26
- Type
- protein
- Length
- 530 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P50172
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | — | protein | 265 | — | P50172 |
Compared structures
- 4K26 · 4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the… · the same entry in another collection · chain A against A, TM-score 1.00
- P50172 · AlphaFold monomer V2.0 prediction for corticosteroid 11-beta- dehydrogenase isozyme 1… · a predicted model of the same protein · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P50172
- Elsewhere: RCSB PDB 4K26 · PDBe 4K26 · UniProt P50172
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.